Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Spotify.Pharrel Wiliams/iStock via Getty ImagesSeeking Alpha News QuizUp for a challenge? Test your knowledge on the biggest events in the investing world over the past week. Take the latest Seeking Alpha News Quiz and see how you stack up against the competition.This week will see Wall Street transition from 2025 to 2026. Markets are shut on January 1, New Year's Day, and trading volume is expected to be low.For investors, catalysts will be few as the economic calendar is light and there are no Federal Reserve speakers on the docket. The minutes of the central bank's December monetary policy committee meeting will be published on Tuesday.Traders will also be on the lookout for a Santa Claus rally - a historical trend that has seen the benchmark S&P 500 index (SP500) post gains across the last five trading days of the year and the first two of the next year. The rally got off to a good start on Christmas Eve but faltered slightly on Friday. Still, the S&P is on track for another year of double-digit percentage gains.EarningsEarnings Spotlight: Thursday: Lifecore Biomedical (LFCR). See the full earnings calendar.Earnings Spotlight: Friday: Taylor Devices (TAYD), Hurco (HURC). See the full earnings calendar.The Dividend Kings is led by Scott Kaufman, a veteran income investor with over a decade of banking and investing experience and a disciplined, cash-flow-first approach to dividend investing. Alongside Rachel Kaufman, the team brings deep expertise in portfolio management and clear, fundamentals-driven research. Analysts Kody Kester and Justin Law add specialized insight into dividend growth, cash-flow durability, and value investing - helping members build sustainable, long-term income portfolios with confidence.Here are two of their latest takes:(Full Article) The article examines the rapid rise of GLP-1 weight-loss drugs and highlights Novo Nordisk (NVO) as a compelling long-term dividend investment. Novo, a global leader in chronic disease treatment, benefits from massive unmet demand in obesity, diabetes, and cardiovascular care, driven by its blockbuster semaglutide drugs Ozempic, Wegovy, and Rybelsus. Despite rising competition and near-term growth moderation, Novo’s strong pipeline, production expansion, and cost-cutting efforts support future earnings growth. The company’s solid balance sheet, AA- credit rating, 3.6% dividend yield, and strong dividend growth make it attractive for income investors. With shares trading well below historical valuation averages, the stock offers both income and meaningful upside potential.(Full Article) The article examines Philip Morris International (PM) as a modern tobacco company transitioning toward a smoke-free future. While smoking’s health risks are well known, PM has adapted by expanding reduced-risk products like IQOS, Zyn, and Veev, which now account for about 41% of revenue. Strong pricing power, rising adoption of smoke-free products, and disciplined cost control have driven solid revenue growth, margin expansion, and double-digit EPS growth. PM offers an attractive ~4% dividend yield with room for continued increases. Trading near fair value, the stock could deliver solid total returns, though risks include illicit trade and higher taxation on reduced-risk products.Join The Dividend Kings to build a resilient, income-focused portfolio with clarity and confidence. The service delivers concise, fundamentals-first research, a market-beating model portfolio, and actionable dividend ideas across risk profiles. Start with a special introductory first month for just $30 and gain a practical “pocket reference” for growing income, capital preservation, and long-term returns. Learn more >>In case you missed itSA Asks: What's the best silver play right now?Winter storm in U.S. northeast cancels over 1,000 flightsChina drafts rules to regulate human-like AI systemsPrecious metals extend shine, with silver and gold hitting recordsNebius is the best-performing systems software stock YTDTechnology sector soars 25% in 2025Tepco to partially restart world's biggest nuclear power plantTarget sees activist investor action